Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


123456789>>>
521 Items
Title  Creator  Group name  Publishing year 
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1) Assenat et al. EquipeMY 2021-02-01
[Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?] Adenis et al. EquipeMY Jan 21, 2020
Towards systematic nomenclature for cell-free DNA Bronkhorst et al. EquipeMY Oct 29, 2020
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27) Samalin et al. EquipeMY May 15, 2020
SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure Thierry and Roch EquipeMY 06 26, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study Cohen et al. EquipeMY 11/2020
Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy Thierry and Roch EquipeMY Sep 11, 2020
Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening Tanos et al. EquipeMY Sep 2020
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study Selvy et al. EquipeMY Jul 27, 2020
Hypoxia differently modulates the release of mitochondrial and nuclear DNA Otandault et al. EquipeMY Jan 13, 2020
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative Cohen et al. EquipeMY 05/2020
Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19? Thierry EquipeMY Jun 03, 2020
Diversity of Tumor-Infiltrating, ?? T-Cell Abundance in Solid Cancers Chabab et al. EquipeMY Jun 24, 2020
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer Jacot et al. EquipeMY Aug 01, 2020
BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer Jacot et al. EquipeMY 2020-03-30
Blood contains circulating cell-free respiratory competent mitochondria Al Amir Dache et al. EquipeMY Jan 19, 2020
Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19 Thierry EquipeMY 10 01, 2020
[Tumor banks and complex data management: Current and future challenges] Hofman et al. EquipeMY Feb 25, 2019
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?] Riou et al. EquipeMY Aug 20, 2019
[Biomarker, what is the pathologist's role?] Bibeau EquipeMY Jun 2019
[Augmented pathology, future or present ?] Badoual and Bibeau EquipeMY Mar 14, 2019
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review Charton et al. EquipeMY Nov 27, 2019
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients You et al. EquipeMY Dec 23, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma Lutz et al. EquipeMY Mar 14, 2019
Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model Chauvin et al. PlateformePP2I 2019
123456789>>>
521 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés